.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Chubb
Baxter
Harvard Business School
Accenture
UBS
Cipla
Colorcon
Julphar

Generated: June 27, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Pierre Fabre

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
9477AII11/25/1991PIERRE FABRE MEDICAMENTVINORELBINE TARTRATE
9642IV3/27/1992PIERRE FABRE MEDICAMENT PRODUCTION AQUITAINE PHARM INTERNATIONALSTERILE MANUFACTURING FACILITY IN PAU IDRON, FRANCE
9973III11/23/1992PIERRE FABRE MEDICAMENT PRODUCTION AQUITAINE PHARM INTERNATIONALNAVELBINE FOR INJECTION
11501AII5/11/1995PIERRE FABRE MEDICAMENTMILNACIPRAN HYDROCHLORIDE (PROCESS I)
11527III5/11/1995PIERRE FABRE SANTEMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GAILLAC, FRANCE.
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Dow
Citi
Harvard Business School
UBS
Chinese Patent Office
Accenture
Covington
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot